PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Ascorbic Acid (Vitamin C)- FDA 20 Drug Disease Ulcers 45,142 1 0.00 -0.97 0.05 0.59
Cyclooxygenase-3 20 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
Cyclooxygenase-3 20 Target Disease Inflammation 252,734 3 0.00 -0.92 0.15 0.58
Dracorhodin 20 Drug Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
Dracorhodin 20 Drug Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
Dracorhodin 20 Drug Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
Kaad-Cyclopamine 19 Drug Disease Basal Cell Carcinoma 7,953 1 0.00 -0.97 0.05 0.63
Kallikrein-8 19 Target Disease Lung Cancer 91,416 1 0.00 -0.97 0.05 0.58
Kallikrein-8 19 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
Kallikrein-8 19 Target Disease Psoriasis 26,882 2 0.00 -0.95 0.11 0.62
Kallikrein-8 19 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
Amitiza (Lubiprostone)- FDA 19 Drug Disease Constipation 15,810 16 0.03 -0.40 0.84 0.69
ALK Phos 19 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
ALK Phos 19 Target Disease Cholesterol 182,390 3 0.00 -0.92 0.16 0.58
ALK Phos 19 Target Target CD146 729 1 0.01 -0.97 0.05 0.70
AMAC-1 19 Target Disease Inflammation 252,734 5 0.00 -0.86 0.26 0.59
AMAC-1 19 Target Disease Septic Arthritis 4,121 1 0.00 -0.97 0.05 0.65
AMAC-1 19 Target Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
Tegument Protein Vp16 19 Target Disease Genital Herpes 2,660 2 0.01 -0.95 0.11 0.68
Tegument Protein Vp16 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
Tegument Protein Vp16 19 Target Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
AMAC-1 19 Target Target CCL3 1,427 1 0.01 -0.97 0.05 0.68
AMAC-1 19 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -0.97 0.05 0.58
AMAC-1 19 Target Target CCL2 3,560 1 0.00 -0.97 0.05 0.65
464.1 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
464.1 19 Target Disease Asthma 109,610 1 0.00 -0.97 0.05 0.57
Aralen (Chloroquine)- FDA 19 Drug Disease Infectious Diseases 33,605 1 0.00 -0.97 0.05 0.60
Aralen (Chloroquine)- FDA 19 Drug Disease Infection 766,637 2 0.00 -0.95 0.11 0.55
Aralen (Chloroquine)- FDA 19 Drug Disease Stroke 146,992 1 0.00 -0.97 0.05 0.57
Aralen (Chloroquine)- FDA 19 Drug Disease Shock 134,031 2 0.00 -0.95 0.11 0.58
Aralen (Chloroquine)- FDA 19 Drug Drug Acetaminophen (Tylenol)- FDA 69 1 0.03 -0.97 0.05 0.79
Aralen (Chloroquine)- FDA 19 Drug Disease Arthritis 128,324 3 0.00 -0.92 0.16 0.59
Kallikrein-8 19 Target Disease Breast Cancer 173,695 2 0.00 -0.95 0.11 0.58
Kallikrein-8 19 Target Disease Inflammation 252,734 2 0.00 -0.95 0.11 0.57
464.1 19 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
Kallikrein-8 19 Target Disease Glioblastoma 17,933 1 0.00 -0.97 0.05 0.61
Complement Decay-Accelerating Factor 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
Complement Decay-Accelerating Factor 19 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
Complement Decay-Accelerating Factor 19 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
Complement Decay-Accelerating Factor 19 Target Disease Rheumatoid Arthritis 78,952 2 0.00 -0.95 0.11 0.59
Complement Decay-Accelerating Factor 19 Target Disease Chronic Lymphocytic Leukemia 11,642 1 0.00 -0.97 0.05 0.62
Complement Decay-Accelerating Factor 19 Target Disease Arthritis 128,324 3 0.00 -0.92 0.16 0.59
Complement Decay-Accelerating Factor 19 Target Disease Infection 766,637 1 0.00 -0.97 0.05 0.53
Complement Decay-Accelerating Factor 19 Target Target Calmodulin 25,240 1 0.00 -0.97 0.05 0.60
Complement Decay-Accelerating Factor 19 Target Disease Cancer 1,053,491 2 0.00 -0.95 0.11 0.54
Complement Decay-Accelerating Factor 19 Target Target CEA 17,022 1 0.00 -0.97 0.05 0.61
Doxacurium Chloride 19 Drug Drug Droperidol 1,957 1 0.01 -0.97 0.05 0.67
Doxacurium Chloride 19 Drug Disease Depression 220,092 3 0.00 -0.92 0.16 0.58
Doxacurium Chloride 19 Drug Disease Stroke 146,992 2 0.00 -0.95 0.11 0.58
Amitiza (Lubiprostone)- FDA 19 Drug Drug Alprostadil (Prostin VR Pediatric)- FDA 26 14 0.63 -0.35 0.74 0.96